<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>大叔快评 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-05T13:09:55+08:00</updated>
  <subtitle>肿瘤学临床研究及制药企业研发评述</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>NEJM:瑞德西韦治疗新冠肺炎临床研究最终结果</title>
    <updated>2020-11-05T11:25:12+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-05:/s/KwH5JfYqQ5xV-cNhew3OPw</id>
    <link href="https://mp.weixin.qq.com/s/KwH5JfYqQ5xV-cNhew3OPw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《东方卫视》对话武田全球执行副总裁里卡多·马雷克</title>
    <updated>2020-11-04T16:01:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-04:/s/Z1yMTWV6Zolc7M0m8C3cRg</id>
    <link href="https://mp.weixin.qq.com/s/Z1yMTWV6Zolc7M0m8C3cRg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>吴一龙教授NEJM：奥希替尼治疗切除术后的EGFR突变型非小细胞肺癌</title>
    <updated>2020-11-03T23:02:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/jAvRb0ouLW8NswmlQdp6EA</id>
    <link href="https://mp.weixin.qq.com/s/jAvRb0ouLW8NswmlQdp6EA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>CD30学院 | 周辉教授——弥漫大B细胞淋巴瘤治疗进展</title>
    <updated>2020-11-03T23:02:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-03:/s/2tR55_tNSsNpBWzMzI0X1w</id>
    <link href="https://mp.weixin.qq.com/s/2tR55_tNSsNpBWzMzI0X1w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田中国将亮相进博会：1000只千纸鹤的祝福</title>
    <updated>2020-11-02T15:20:10+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-02:/s/25WhQzCURI0fOYWe9uqnDw</id>
    <link href="https://mp.weixin.qq.com/s/25WhQzCURI0fOYWe9uqnDw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>武田制药：未来要把15款以上创新药物引入中国</title>
    <updated>2020-11-01T11:52:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/V2gfqyTwvHWyjN9qNUPLIg</id>
    <link href="https://mp.weixin.qq.com/s/V2gfqyTwvHWyjN9qNUPLIg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>A+学院 | 王书杰教授：未来可期——纵览血友病诊疗新进展</title>
    <updated>2020-11-01T11:52:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/sXh41DovJ3gF7hjINRhdYQ</id>
    <link href="https://mp.weixin.qq.com/s/sXh41DovJ3gF7hjINRhdYQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>鲁比卡丁Lurbinectedin中文说明书</title>
    <updated>2020-11-01T11:52:20+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-11-01:/s/lUFTxlMQscEhV8VGLppwXg</id>
    <link href="https://mp.weixin.qq.com/s/lUFTxlMQscEhV8VGLppwXg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>《第一声音》对话武田中国总裁单国洪</title>
    <updated>2020-10-28T21:46:21+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/SA-6WTy2QC0eeZqPEjbJzQ</id>
    <link href="https://mp.weixin.qq.com/s/SA-6WTy2QC0eeZqPEjbJzQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【王景文教授点评】J Hematol Oncol | 复发HL、ALCL患者再次接受BV缓解率高及安全性可控</title>
    <updated>2020-10-28T17:51:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-28:/s/MffmORhA0SICOHC2vQ_6hQ</id>
    <link href="https://mp.weixin.qq.com/s/MffmORhA0SICOHC2vQ_6hQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>KRAS G12C抑制剂MRTX849和AMG510临床数据更新和比较</title>
    <updated>2020-10-26T22:18:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/veOWe9-ojoUbUnUv1xkYnw</id>
    <link href="https://mp.weixin.qq.com/s/veOWe9-ojoUbUnUv1xkYnw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药物警戒从幕后到前台，冲锋号已经吹响！</title>
    <updated>2020-10-26T22:18:56+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-26:/s/pkYqUCBl4SDVitM9i75byQ</id>
    <link href="https://mp.weixin.qq.com/s/pkYqUCBl4SDVitM9i75byQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>真实世界数据研究用于药品及医疗器械的评价</title>
    <updated>2020-10-25T22:04:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-25:/s/zNFYzjblmg7nHUn0tf0ALw</id>
    <link href="https://mp.weixin.qq.com/s/zNFYzjblmg7nHUn0tf0ALw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>【NACLC20】PD-1/PD-L1单抗治疗驱动基因阳性NSCLC的PFS差异</title>
    <updated>2020-10-25T22:04:45+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-25:/s/OlbCcrfsZEamOgD-WRMPtA</id>
    <link href="https://mp.weixin.qq.com/s/OlbCcrfsZEamOgD-WRMPtA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>智胜科技与医疗，共建数字化创新医疗生态圈</title>
    <updated>2020-10-23T08:41:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-23:/s/RuLpuQaqr6tyhO63MHuThg</id>
    <link href="https://mp.weixin.qq.com/s/RuLpuQaqr6tyhO63MHuThg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>钟立业教授解读 | 真实世界初治多发性骨髓瘤长程管理中PIs同类药物转换治疗可行性： US-MM6最新数据解读</title>
    <updated>2020-10-23T08:41:02+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-10-23:/s/o1E977ZYYt75s9z-l7s-Kw</id>
    <link href="https://mp.weixin.qq.com/s/o1E977ZYYt75s9z-l7s-Kw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>